Personalised Approach to Diagnosing and Managing Ischemic Stroke with a Plasma-Soluble Urokinase-Type Plasminogen Activator Receptor

Personalised Approach to Diagnosing and Managing Ischemic Stroke with a Plasma-Soluble Urokinase-Type Plasminogen Activator Receptor

Background: The increasing incidence of ischemic stroke has led to the search for a novel biomarker to predict the course of disease and the risk of mortality. Recently, the role of the soluble urokinase plasminogen activator receptor (suPAR) as a biomarker and indicator of immune system activation...

Full description

Bibliographic Details
Main Authors: Katarzyna Śmiłowska, Marek Śmiłowski, Robert Partyka, Danuta Kokocińska, Przemysław Jałowiecki
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Journal of Personalized Medicine
Subjects:
stroke
ischemia
biomarkers
mortality risk
Online Access:https://www.mdpi.com/2075-4426/12/3/457

Similar Items

Similar Items